keyword
https://read.qxmd.com/read/17343193/-the-clinical-features-of-b-cell-lymphoblastic-lymphoma-and-outcomes-after-bfm-90-regimen-therapy
#21
JOURNAL ARTICLE
Xiao-fei Sun, Zi-jun Zhen, Yi Xia, Qun-ying Yang, Zhi-hui Wang, Jia-yu Ling
OBJECTIVE: To analyse the clinical features of patients with B cell lymphoblastic lymphoma(BCLL) and the outcomes after modified BFM-90 protocol therapy. METHODS: The clinical features of 14 patients with BCLL were analysed, and compared with that of T cell lymphoblastic lymphoma in the same period. The efficacy and toxicity of modified BFM-90 protocol were analysed. RESULTS: The 14 patients were aged 3 to 18 and diagnosed as BCLL by morphology and immunohistology...
October 2006: Zhonghua Xue Ye Xue za Zhi, Zhonghua Xueyexue Zazhi
https://read.qxmd.com/read/17102815/diagnosis-and-prognosis-of-b-cell-chronic-lymphocytic-leukemia-small-lymphocytic-lymphoma-b-cll-sll-and-mantle-cell-lymphoma-mcl
#22
JOURNAL ARTICLE
Nancy Yousef Asaad, Moshira Mohamed Abd El-Wahed, Marwa Mohammed Dawoud
BACKGROUND: B-cell chronic lymphocytic leukemia/ small lymphocytic lymphoma (B-CLL/SLL) and mantle cell lymphoma (MCL) show many overlapping morphologic and immunophenotyping features, however they have great difference in therapeutic regimens and prognosis. THE AIM OF THE STUDY: Is to determine the diagnostic and prognostic role of clinico-pathologic variables, CD23 and Cyclin D1 oncoprotiens in B-SLL/CLL and MCL. PATIENTS AND METHODS: This study included 25 BCLL/ SLL cases and 25 MCL cases...
December 2005: Journal of the Egyptian National Cancer Institute
https://read.qxmd.com/read/17018893/high-risk-fludarabine-pretreated-b-cell-chronic-lymphocytic-leukemia-s-high-response-rate-following-sequential-dhap-and-alemtuzumab-administration-though-in-absence-of-molecular-remission
#23
JOURNAL ARTICLE
Ignazio Majolino, Marco Ladetto, Anna Locasciulli, Daniela Drandi, Fabio Benedetti, Andrea Gallamini, Teodoro Chisesi, Angelo De Blasio, Mario Boccadoro, Corrado Tarella
B-CLL patients with resistant/relapsed disease or adverse prognostic factors at presentation are suitable for alternative treatments. In the present pilot study we investigated a novel intensive chemo-immunotherapy approach for high-risk, fludarabine pretreated patients. Ten patients with resistant/relapsed, advanced stage BCLL were included. Age was 37-60 yr (median 53). All but one had an unmutated IgVH status. The treatment schedule included debulking with two DHAP courses followed by alemtuzumab (30 mg, eight doses), followed by peripheral blood progenitor cell (PBPC) mobilization with intermediate/high-dose cyclophosphamide and by autografting after high-dose mitoxantrone+L-Pam...
2006: Medical Oncology
https://read.qxmd.com/read/16601371/minimal-change-glomerulonephritis-in-chronic-lymphocytic-leukemia-pathophysiological-and-therapeutic-aspects
#24
JOURNAL ARTICLE
Meritxell Garcia Alzamora, Markus Schmidli, Urs Hess, Richard Cathomas, Roger von Moos
BACKGROUND: So far, only 9 cases of minimal change glomerulonephritis (MCGN) related to chronic lymphocytic leukemia (CLL) have been described. CASE REPORT: Our patient presented with severe nephrotic syndrome. Diagnostic biopsies confirmed MCGN and early-stage BCLL (Binet A). In contrast to previously described cases, kappa monoclonal IgM and cryoglobulins were also detected. The patient was treated with chlorambucil and prednisone. 3 weeks later, renal function and white blood cell (WBC) count were completely normal...
April 2006: Onkologie
https://read.qxmd.com/read/16498670/unsupervised-immunophenotypic-profiling-of-chronic-lymphocytic-leukemia
#25
JOURNAL ARTICLE
Luzette K Habib, William G Finn
BACKGROUND: Proteomics and functional genomics have revolutionized approaches to disease classification. Like proteomics, flow cytometry (FCM) assesses concurrent expression of many proteins, with the advantage of using intact cells that may be differentially selected during analysis. However, FCM has generally been used for incremental marker validation or construction of predictive models based on known patterns, rather than as a tool for unsupervised class discovery. We undertook a retrospective analysis of clinical FCM data to assess the feasibility of a cell-based proteomic approach to FCM by unsupervised cluster analysis...
May 2006: Cytometry. Part B, Clinical Cytometry
https://read.qxmd.com/read/16338412/crystal-structure-of-the-restriction-modification-system-control-element-c-bcll-and-mapping-of-its-binding-site
#26
JOURNAL ARTICLE
Michael R Sawaya, Zhenyu Zhu, Fana Mersha, Siu-Hong Chan, Rajesh Dabur, Shuang-Yong Xu, Ganesaratnam K Balendiran
Protection from DNA invasion is afforded by restriction-modification systems in many bacteria. The efficiency of protection depends crucially on the relative expression levels of restriction versus methytransferase genes. This regulation is provided by a controller protein, named C protein. Studies of the Bcll system in E. coli suggest that C.Bcll functions as a negative regulator for M.Bcll expression, implying that it plays a role in defense against foreign DNA during virus infection. C.Bcll binds (Kd = 14...
December 2005: Structure
https://read.qxmd.com/read/15531194/smooth-muscle-cell-apoptosis-in-primary-varicose-veins
#27
JOURNAL ARTICLE
T Urbanek, B Skop, R Wiaderkiewicz, T Wilczok, K Ziaja, T Lebda-Wyborny, K Pawlicki
OBJECTIVES: One of the important factors responsible for vessel wall remodelling is programmed cell death. In the paper the role of smooth muscle cell (SMC) apoptosis in primary varicose veins (PVV) is investigated. MATERIAL AND METHODS: Vein specimens were obtained from 40 patients with PVV. In each case proximal and distal (upper crural) great saphenous veins (GSV) were harvested. Morphometric computer assessed quantitative evaluation of SMCs, collagen and elastin content was carried out...
December 2004: European Journal of Vascular and Endovascular Surgery
https://read.qxmd.com/read/14736815/identification-of-genes-involved-in-apoptosis-and-dominant-follicle-development-during-follicular-waves-in-cattle
#28
JOURNAL ARTICLE
A C O Evans, J L H Ireland, M E Winn, P Lonergan, G W Smith, P M Coussens, J J Ireland
We hypothesize that granulosa and theca cells from growing dominant follicles, with relatively high intrafollicular concentrations of estradiol, have a greater expression of genes involved in inhibiting apoptosis pathways and lower expression of genes involved in apoptosis pathways than growing subordinate follicles with lower estradiol concentrations. Using the well-characterized bovine dominant follicle model, we collected granulosa and theca cells from individual dominant and the largest subordinate follicle 3 days after initiation of a follicular wave in four animals...
May 2004: Biology of Reproduction
https://read.qxmd.com/read/14695232/the-pattern-and-distribution-of-immunoglobulin-vh-gene-mutations-in-chronic-lymphocytic-leukemia-b-cells-are-consistent-with-the-canonical-somatic-hypermutation-process
#29
JOURNAL ARTICLE
Bradley T Messmer, Emilia Albesiano, Davorka Messmer, Nicholas Chiorazzi
The overexpanded clone in most B-cell-type chronic lymphocytic leukemia (BCLL) patients expresses an immunoglobulin (Ig) heavy chain variable (V(H)) region gene with some level of mutation. While it is presumed that these mutations were introduced in the progenitor cell of the leukemic clone by the canonical somatic hypermutation (SHM) process, direct evidence of such is lacking. Nucleotide sequences of the Ig V(H) genes from 172 B-CLL patients were analyzed. Previously described V(H) gene usage biases were noted...
May 1, 2004: Blood
https://read.qxmd.com/read/12599176/b-cell-monoclonal-lymphocytosis-and-b-cell-abnormalities-in-the-setting-of-familial-b-cell-chronic-lymphocytic-leukemia
#30
JOURNAL ARTICLE
Gerald E Marti, Patricia Carter, Fatima Abbasi, Glennelle C Washington, Nisha Jain, Vincent E Zenger, Naoko Ishibe, Lynn Goldin, Laura Fontaine, Nancy Weissman, Maria Sgambati, Guy Fauget, Pablo Bertin, Robert F Vogt, Barbara Slade, Philip D Noguchi, M A Stetler-Stevenson, Neil Caporaso
BACKGROUND: Among all hematologic malignancies, B-cell chronic lymphocytic leukemia (BCLL) has the highest familial clustering (three- to sevenfold increase), strongly suggesting a genetic component to its etiology. Familial BCLL can be used as a model to study the early pathogenesis of this disease. METHODS: We examined nine kindreds from the National Cancer Institute's Familial BCLL Registry, consisting of 19 affected members with BCLL and 33 clinically unaffected first-degree relatives...
March 2003: Cytometry. Part B, Clinical Cytometry
https://read.qxmd.com/read/12586635/the-resistance-of-b-cll-cells-to-dna-damage-induced-apoptosis-defined-by-dna-microarrays
#31
JOURNAL ARTICLE
Laurent Vallat, Henri Magdelénat, Helene Merle-Béral, Peggy Masdehors, Gabrielle Potocki de Montalk, Frédéric Davi, Mogens Kruhoffer, Laure Sabatier, Torben F Orntoft, Jozo Delic
B-cell chronic lymphoid leukemia (BCLL) is a highly heterogeneous human malignancy, presumably reflecting specific molecular alterations in gene expression and protein activity that are thought to underlie the variable disease outcome. Most B-CLL cell samples undergo apoptotic death in response to DNA damage. However, a clinically distinct aggressive subset of B-CLL is completely resistant in vitro to irradiation-induced apoptosis. We therefore addressed 2 series of microarray analyses on 4 sensitive and 3 resistant B-CLL cell samples and compared their gene expression patterns before and after apoptotic stimuli...
June 1, 2003: Blood
https://read.qxmd.com/read/12384436/prognostic-value-of-enhanced-bone-marrow-angiogenesis-in-early-b-cell-chronic-lymphocytic-leukemia
#32
COMPARATIVE STUDY
Stefano Molica, Angelo Vacca, Domenico Ribatti, Antonio Cuneo, Francesco Cavazzini, Domenico Levato, Gaetano Vitelli, Luigi Tucci, Aldo M Roccaro, Franco Dammacco
Because tumor progression is angiogenesis-dependent, angiogenesis density was investigated by immunohistochemistry and computed image analysis in bone marrow (BM) biopsies of 45 newly diagnosed patients with Binet stage A B-cell chronic lymphocytic leukemia (BCLL) and correlated to upstaging and progression-free survival during a 40-month follow-up period. Their microvessel areas and counts were significantly higher than those of patients with anemia due to iron or vitamin B(12) deficiencies. A cutoff value of 0...
November 1, 2002: Blood
https://read.qxmd.com/read/12217913/multi-class-cancer-classification-via-partial-least-squares-with-gene-expression-profiles
#33
COMPARATIVE STUDY
Danh V Nguyen, David M Rocke
MOTIVATION: Discrimination between two classes such as normal and cancer samples and between two types of cancers based on gene expression profiles is an important problem which has practical implications as well as the potential to further our understanding of gene expression of various cancer cells. Classification or discrimination of more than two groups or classes (multi-class) is also needed. The need for multi-class discrimination methodologies is apparent in many microarray experiments where various cancer types are considered simultaneously...
September 2002: Bioinformatics
https://read.qxmd.com/read/12079276/characterization-of-fam10a4-a-member-of-the-st13-tumor-suppressor-gene-family-that-maps-to-the-13q14-3-region-associated-with-b-cell-leukemia-multiple-myeloma-and-prostate-cancer
#34
JOURNAL ARTICLE
Khalid Sossey-Alaoui, Eiko Kitamura, Karen Head, John K Cowell
Using the 650-kb DNA sequence from the minimally deleted region in B-cell chronic lymphocytic leukemia (BCLL), we have identified a new gene, FAM10A4, that maps to the proximal end of the region. This gene has been shown to be part of a now six-member family of genes with high homology to the ST13 tumor suppressor gene. We have established conditions to specifically undertake mutation studies of the chromosome 13 member of this family and have identified a Ser71Leu change in BCLL samples, which is apparently a polymorphism...
July 2002: Genomics
https://read.qxmd.com/read/12006207/selection-of-autologous-cd4-t-cells-for-adoptive-t-cell-substitution-in-patients-with-cd23-b-cell-cll
#35
JOURNAL ARTICLE
M Dettke, R Berger, S Jurko, G Mitterbauer, J D Schwarzmeier, P Höcker
BACKGROUND: B-cell CLL (B-CLL) is accompanied by a progressive decrease in cellular immune functions, and treatment-related immunosuppression can further aggravate T-cell immunodeficiency. To reduce the risks of T-cell depletion, it seems feasible to collect autologous CD4+ cells at an early disease stage and subsequently reinfuse them during periods of profound T-cell depletion. METHOD: We describe a two-step cell-selection method to obtain highly enriched CD4+ T-cells from leukapheresis compounds of patients with CD23+ B-CLL...
2002: Cytotherapy
https://read.qxmd.com/read/11836210/tumor-classification-by-partial-least-squares-using-microarray-gene-expression-data
#36
COMPARATIVE STUDY
Danh V Nguyen, David M Rocke
MOTIVATION: One important application of gene expression microarray data is classification of samples into categories, such as the type of tumor. The use of microarrays allows simultaneous monitoring of thousands of genes expressions per sample. This ability to measure gene expression en masse has resulted in data with the number of variables p(genes) far exceeding the number of samples N. Standard statistical methodologies in classification and prediction do not work well or even at all when N < p...
January 2002: Bioinformatics
https://read.qxmd.com/read/11758257/-defective-expression-of-b7-2-in-b-cell-chronic-lymphocytic-leukemia-b-cells
#37
JOURNAL ARTICLE
Z Dai, X Xu, Q Chen
OBJECTIVE: To investigate the expression of B7.1 and B7.2 molecules in peripheral B cells of patients with chronic B cell lymphocytic leukemia (BCLL) and to study the relationship between B7.1 and B7.2 expression and pathogenic mechanism of BCLL. METHODS: Peripheral blood mononuclear cells (PBMC) were separated by Ficoll-Hypaque lymphocytes separation medium from 25 normal persons (normal control group) and 23 BCLL patients (BCLL group) which were further divided into two groups, phase 0-II group and phase III-IV group...
September 10, 2001: Zhonghua Yi Xue za Zhi [Chinese medical journal]
https://read.qxmd.com/read/11172297/adhesion-molecule-expression-in-cd5-negative-cd10-negative-chronic-b-cell-leukemias-comparison-with-non-hodgkin-s-lymphomas-and-cd5-positive-b-cell-chronic-lymphocytic-leukemia
#38
COMPARATIVE STUDY
W G Finn, T P Singleton, B Schnitzer, C W Ross, L M Stoolman
The classification of CD5-negative/CD10-negative chronic B-cell leukemias (CD5-/CD10- CBL) can be problematic. Most of these cases may represent leukemic non-Hodgkin's lymphoma (NHL) other than B-cell chronic lymphocytic leukemia (BCLL); nonetheless, some investigators still advocate the term "CD5-negative BCLL." Because adhesion molecule (AdMol) expression patterns reflect the biology of lymphoid neoplasms, we studied a series of 106 B-cell lymphoproliferative disorders, including CD5+ BCLL (n = 56), NHL other than BCLL (n = 35), and CD5-/CD10- CBL (excluding hairy cell leukemia and prolymphocytic leukemia) with no prior history of NHL (n = 15) for expression of components of the very late antigen-4 complex (alpha4/beta1 integrin (CD49d/CD29)), components of the mucosal addressin-cell adhesion molecule receptor (alpha4(CD49d)/beta7 integrin), and L-selectin (CD62L)...
January 2001: Human Pathology
https://read.qxmd.com/read/10586378/fas-apo-1-cd95-receptor-expression-in-childhood-astrocytomas-is-it-a-marker-of-the-major-apoptotic-pathway-or-a-signaling-receptor-for-immune-escape-of-neoplastic-cells
#39
JOURNAL ARTICLE
B Bodey, B Bodey, S E Siegel, H E Kaiser
Apoptosis is a physiological process wherein the cell initiates a sequence of events culminating in the fragmentation of its DNA, nuclear collapse, and finally disintegration of the cell into small, membrane-bound apoptotic bodies. Expression of Fas (APO-1, CD95) Receptor (FasR) and programmed or active cell (PCD) death was studied in childhood astrocytomas (ASTRs) with varying stages of malignancy, including pilocytic ASTR, low grade ASTR, anaplastic ASTR, and glioblastoma multiforme (GBM). The great majority of childhood glial tumors, particularly ASTRs express FasR whereas normal cells in the central nervous system (CNS) do not...
July 1999: In Vivo
https://read.qxmd.com/read/10088037/construction-of-a-bacterial-artificial-chromosome-bac-contig-across-the-minimally-deleted-region-in-13q14-3-in-b-cell-chronic-lymphocytic-leukemia
#40
JOURNAL ARTICLE
L A Hawthorn, J K Cowell
Loss of heterozygosity (LOH) analysis in B-cell chronic lymphocytic leukemia (BCLL) has indicated that a frequent genetic event is loss of alleles from an approximately 500 kb region in 13q14.3, distal to the retinoblastoma gene. We have used DNA markers from this region to isolate and characterize a series of bacterial artificial chromosomes (BACs) which span the region between markers D13S319 and D13S25, which represents the common region of LOH. This entire region appears to be contained within only two minimally overlapping BACs, representing a maximum distance of approximately 350 kb...
September 1998: Annals of Human Genetics
keyword
keyword
160207
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.